The effect of galanin was studied on the release of growth hormone (GH) from perifused medial basal hypothalami (MBH) and/or adenohypophyses of steers in a sequential double chamber perifusion system.
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Abstract
The effect of galanin was studied on the release of growth hormone (GH) from perifused medial basal hypothalami (MBH) and/or adenohypophyses of steers in a sequential double chamber perifusion system.
Galanin stimulated significant GH release at the doses of 10-7, 10-8 (P<0.01) and 10-9M (P<0.05) in perifusion groups containing pituitary fragments alone compared with control perifusion group. The elevation induced by galanin in perifusion groups containing pituitary fragment alone tended to be in a dose dependent manner.
In contrast to these results, galanin stimulated significant GH release only at the dose of 10-7M in perifusion groups containing both the hypothalamus and pituitary fragments in tandem (P<0.01). Galanin, a 29-amino acid peptide originally discovered in the porcine intestine20), has been found to be widely distributed in the mammalian central nervous system4,15,18,19). The peptide is known to stimulate pituitary growth hormone (GH) release in rats6,11,13,14,16,17) and humans1,5,10). The hypothalamic site of galanin action to release GH has been suggested, since intraventricular injections of galanin stimulated GH release, but failed to stimulate GH release from the adenohypophyses in vitro16,17) On the contrary to this report, galanin acts directly on rat anterior pituitary cells stimulating GH release6). Considering these controversial results, we examined to explore whether galanin stimulates the release of GH indirectly through the hypothalamus or directly on the adenohypophysis. Moreover, the effect of galanin on GH secretion in domestic animals has not been elucidated. The medial part of the sagittal halves of the pituitary glands was sectioned into small cubes of 1.5mm dimensions.
The medial basal hypothalamic tissue prepared for perifusion was limited dorsally 3mm deep, frontally by the caudal border of the optic chiasm, laterally by 1mm lateral to the tuber cinereum, and caudally by the rostral border of the mamillary body. The MBH included the pituitary stalk.
Anterior pituitary perifusion:
The perifusion system was a modified method of MIYAKE and YEN12). Five cubes of the anterior pituitary fragments were loaded into a small plastic chamber of 0.2ml size and were perifused at with 95% O2 and 5% CO2, After equilibration for 3h, the effluent was collected in 3ml fractions at 10min intervals at a flow rate of 18ml/h.
The validity of the system used in the experiment was confirmed in our previous study7). Six samples of the effluent were collected first over a period of 1h for determinations of basal control values. Solutions containing various concentrations (10-7, 10-8 and 10-9M) of galanin (Sigma Chemical Co., St. Louis, MO, U.S.A.) or the modified KRB solution alone (control) were then perifused for the next 1.0h. After these period of treatments, the modified KRB solution was perifused again for the next 1. Radioimmunoassay (RIA): GH in effluent fractions was determined by RIA as described previously9). The GH standard preparation used and hormone for iodination were bGH-B1. The hormone was supplied by the USDA Reproduction Laboratory, Beltsville MD. Bovine growth hormone (bGH) antiserum to bGH prepared in monkeys was supplied by Dr. JOHKE, T,, National Institute of Animal Industry, Japan, and goat anti-monkey IgG serum (2nd antibody) was supplied by Dr. WAKABA-YASHI, K., Institute of Endocrinology, Gunma University, Japan. In this assay, the intraand inter-assay coefficients of variation were 1.7 and 16.7%, respectively.
The least detectable value of assay was 2.54ng/ml.
Statistical analysis:
Values during the experiment were expressed as percent changes from means of 6 determinations during the 1h basal control period. Data were presented as of each effluent fraction after the treatment were compared with respective control values. The mean GH concentrations during and after infusion of galanin from each 6 fractions were also compared with the mean value of their respective controls. Statistical comparisons were made by using the Student's t test after the BARTLETT'S test for uniformity of the variances8)
Results
The effects of the various molar concentrations of galanin for the release of GH from the perifusion containing pituitary fragments alone are shown in Figs. 1 and 2. As shown in Fig. 1 , perifusion with the media containing 10-7 and 10-8M galanin for 60min significantly stimulated GH release from the pituitary fragments alone when compared with respective control values (P<0.05, P<0.01).
The increasing rates of mean GH concentrations during the treatments in the 10-7 and 10-8M groups were 37 (P<0.01) and 25% (P<0.01), respec- tively. The elevated levels of GH induced by 10-7M galanin were maintained up to at least 60min after the termination of the perifusion of the peptide (Fig. 2) . The 10-9M galanin also significantly (P<0.05) increased the mean GH concentrations during the treatments compared with the mean GH concentrations of 60-min control perifusion period, but the increasing rates (14%) of the 10-9M galanin was significantly (P<0.05) lower than that (37%) of the 10-7M galanin (Fig. 2) . The elevation induced by galanin in perifusion groups containing pituitary fragment alone tended to be in a dose dependent manner.
The effects of the various molar concentrations of galanin for the release of GH from the perifusion containing pituitary fragments in series with the hypothalamus are shown in Figs. 3 and 4. As shown in Fig. 3 , perifusion with the medium containing 10-7M galanin for 60min significantly stimulated GH release from the pituitary fragments in series with MBH compared with respective control values (P<0.05, P<0.01). The increasing rates of mean GH concentrations during the treatments in the 10-7M group was 32% (P<0.01), and this increase in GH concentrations was maintained up to at least 60min after the termination of the perifusion of the peptide (Fig. 4 ). There were no significant difference at other galanin doses between the control groups and the perifusion groups containing pituitary fragments in series with the hypothalamus.
Discussion
The present study demonstrates that galanin induces GH release directly from the anterior pituitary gland in vitro in cattle.
Heretofore, effects of galanin on the release of pituitary GH have never been reported in domestic animals in vivo as well as in vitro. To our knowledge, the present study is the first demonstration of the effect of galanin in stimulating Other explanations are described in Fig. 1.   culture3 ). Therefore, the inhibitory responses observed in perifusions containing both the pituitary fragments and hypothalamus in series could be attributed to the action of somatotropin release inhibiting factor (SRIF), such as somatostatin.
Further studies such as perifusion of MBH extracts or somatostatin instead of MBH tissues would be necessary in order to clarify the inhibitory responses appeared in the present study.
The GH releasing effect of galanin seems to be weaker than that of GRF since the GH releasing effect of GRF was seen at concentrations as low as 10-11M GRF in the same perifusion system7). The physiological importance of galanin-stimulated GH secretion is uncertain. However, galanin was reported to be a physiological regulator of spontaneous pulsatile secretion of GH in rats11). Also the combined effect of galanin and GRF produces considerably greater GH release than that produced by GRF alone5,6). These findings suggest that galanin may be added to the list of factors that act to modify GRF and somatostatin effects on GH secretion in the cattle.
